Compile Data Set for Download or QSAR
maximum 50k data
Found 467 of affinity data for UniProtKB/TrEMBL: O43283
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637196(US20230382904, Compound 116)
Affinity DataIC50:  14nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637244(US20230382904, Compound 159)
Affinity DataIC50:  16nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637188(US20230382904, Compound 108)
Affinity DataIC50:  25nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637192(2-Amino-N-[(2S)-butan-2-yl]-6-(5-{[(1S)-1-(4-fluor...)
Affinity DataIC50:  29nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637181(US20230382904, Compound 101)
Affinity DataIC50:  29nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637109(US20230382904, Compound 29 | US20230382904, Compou...)
Affinity DataIC50:  30nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637184(US20230382904, Compound 104)
Affinity DataIC50:  30.5nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637218(US20230382904, Compound 138)
Affinity DataIC50:  31nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637174(2-Amino-N-[(2S)-butan-2-yl]-6-(5-{[(1S)-1-(4-fluor...)
Affinity DataIC50:  34nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637157(US20230382904, Compound 77)
Affinity DataIC50:  36nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637168(US20230382904, Compound 88)
Affinity DataIC50:  37nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637074(US20230382904, Compound 21)
Affinity DataIC50:  40nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637173(US20230382904, Compound 93)
Affinity DataIC50:  41nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637195(US20230382904, Compound 115)
Affinity DataIC50:  41nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637240(US20230382904, Compound 155)
Affinity DataIC50:  41nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637221(US20230382904, Compound 141 | US20230382904, Compo...)
Affinity DataIC50:  42nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637227(US20230382904, Compound 144-3)
Affinity DataIC50:  43nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637246(US20230382904, Compound 161)
Affinity DataIC50:  43nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637110(US20230382904, Compound 30)
Affinity DataIC50:  45nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637187(US20230382904, Compound 107)
Affinity DataIC50:  46nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637171(US20230382904, Compound 91)
Affinity DataIC50:  48nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637167(US20230382904, Compound 87)
Affinity DataIC50:  48nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637169(US20230382904, Compound 89)
Affinity DataIC50:  51nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637245(US20230382904, Compound 160)
Affinity DataIC50:  52nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637123(US20230382904, Compound 43 | US20230382904, Compou...)
Affinity DataIC50:  55nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637237(US20230382904, Compound 152)
Affinity DataIC50:  57nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637178(US20230382904, Compound 98)
Affinity DataIC50:  60nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637109(US20230382904, Compound 29 | US20230382904, Compou...)
Affinity DataIC50:  60nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637105(US20230382904, Compound 25)
Affinity DataIC50:  61nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637221(US20230382904, Compound 141 | US20230382904, Compo...)
Affinity DataIC50:  63nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637106(2-Amino-6-(5-{[(1S)-1-(4-fluorophenyl)ethyl]carbam...)
Affinity DataIC50:  68nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637231(US20230382904, Compound 146)
Affinity DataIC50:  71nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637182(US20230382904, Compound 102)
Affinity DataIC50:  71nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637176(US20230382904, Compound 96)
Affinity DataIC50:  76nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637108(US20230382904, Compound 28 | US20230382904, Compou...)
Affinity DataIC50:  77nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637247(US20230382904, Compound 162)
Affinity DataIC50:  77nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637112(US20230382904, Compound 32)
Affinity DataIC50:  78nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637241(US20230382904, Compound 156)
Affinity DataIC50:  79nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637203(US20230382904, Compound 123)
Affinity DataIC50:  83nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637156(US20230382904, Compound 76)
Affinity DataIC50:  87nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637031(2-Amino-6-(5-{[(4-fluorophenyl)methyl]carbamoyl}th...)
Affinity DataIC50:  87.5nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637239(US20230382904, Compound 154)
Affinity DataIC50:  89nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637040(US20230382904, Compound 11)
Affinity DataIC50:  90nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637107(US20230382904, Compound 27)
Affinity DataIC50:  99nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637236(US20230382904, Compound 151)
Affinity DataIC50:  100nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637232(US20230382904, Compound 147)
Affinity DataIC50:  100nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637065(2-Amino-6-(5-{[(1S)-1-(4-fluorophenyl)ethyl]carbam...)
Affinity DataIC50:  109nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637108(US20230382904, Compound 28 | US20230382904, Compou...)
Affinity DataIC50:  110nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637200(US20230382904, Compound 120)
Affinity DataIC50:  110nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMitogen-activated protein kinase kinase kinase 13(Homo sapiens (Human))
The Johns Hopkins University

US Patent
LigandPNGBDBM637223(US20230382904, Compound 143)
Affinity DataIC50:  110nMAssay Description:Assay Protocol for 384 low volume MTP format: 1 μl of test compound was pipetted into test plate; +5 μl LZK solution (10 nM LZK, catalytic ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 467 total ) | Next | Last >>
Jump to: